Repligen Cp (RGEN)
$96.65 0.00 (0.00%)
16:25 EDT RGEN Stock Quote Delayed 20 Minutes
Previous Close $96.65
Market Cap 4.22B
PE Ratio 136.13
Volume (Avg. Vol.)
Day's Range 96.65 - 96.65
52-Week Range 52.87 - 109.94
Dividend & Yield N/A (N/A)
RGEN Stock Predictions, Articles, and Repligen Cp News
- From InvestorPlace
- From the Web
When rumors start buzzing that the government may be about to intervene, then biotech stocks often get slammed...some fairly, and some not (as we’ll see).
This morning, I am recommending a bullish trade on Repligen Corporation (NASDAQ:RGEN), the bioprocessing company.
Investors are in for a wild ride later this week as Under Armour prepares to report its first-quarter earnings results before the open on Thursday.
The following stocks were moving the Manufacturing sector today.
This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Healthcare stocks rose broadly on Wall Street on Thursday morning, with the sector seeing an overall increase of 0.3%.
Healthcare stocks rose broadly on Wall Street on Friday, with the sector seeing an overall increase of 0.6%.
These 7 top-rated biotech stocks are priced right, and are capable of weathering the market's recent downturn.
Healthcare stocks remained flat on Monday morning on Wall Street.
Healthcare stocks advanced broadly on Wall Street on Wednesday morning, with the sector seeing an overall increase of 2.5%.
Healthcare stocks finished flat today on Wall Street.
Healthcare stocks declined on Wall Street on Tuesday morning, down 0.6%.
Healthcare stocks fell on Wall Street on Friday morning, down 0.6%.
Healthcare stocks fell broadly on Wall Street on Thursday morning, with the sector seeing an overall decline of 0.2%.
From Simply Wall St
It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. However, sometimes companies receive a one-off boost (or reduction)<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rgen/repligen/news/repligen-nasdaqrgen-is-growing-earnings-but-are-they-a-good-guide/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader